282. Emergency Department-Initiated Buprenorphine for Opioid Use Disorder: A Randomized Clinical Trial.
作者: Gail D'Onofrio.;Andrew A Herring.;Kathryn F Hawk.;Jeanmarie Perrone.;Ethan Cowan.;Ryan P McCormack.;James Dziura.;Abigail G Matthews.;Michael V Pantalon.;Patricia Owens.;Shara Martel.;Edouard Coupet.;Michele R Lofwall.;Sharon L Walsh.;E Jennifer Edelman.;Joseph E Carpenter.;Tania D Strout.;Michael R Baumann.;Erik Anderson.;Tyler W Barrett.;Alyrene Dorey.;Peter Taillac.;Gerald Cochran.;Cameron S Crandall.;Jason Wilson.;Jacob Manteuffel.;Jon B Cole.;Lauren K Whiteside.;Christopher Jones.;Elizabeth Samuels.;Kristen Huntley.;David A Fiellin.; .
来源: JAMA. 2026年335卷11期948-960页
Extended-release injectable buprenorphine may expand the reach of initiating medications for opioid use disorder in high-risk and hard-to-reach individuals who visit the emergency department (ED) and can be administered in low levels of withdrawal.
290. Coffee and Tea Intake, Dementia Risk, and Cognitive Function.
作者: Yu Zhang.;Yuxi Liu.;Yanping Li.;Yuhan Li.;Xiao Gu.;Jae H Kang.;A Heather Eliassen.;Molin Wang.;Eric B Rimm.;Walter C Willett.;Frank B Hu.;Meir J Stampfer.;Dong D Wang.
来源: JAMA. 2026年335卷11期961-974页
Evidence linking coffee and tea to cognitive health remains inconclusive, and most studies fail to differentiate caffeinated from decaffeinated coffee.
|